China Shineway Pharmaceutical Group Limited (C1S) — Free Cash Flow Generation Index
China Shineway Pharmaceutical Group Limited (C1S) has a Free Cash Flow Generation Index of 1.15x as of June 2023. Free cash flow of €185.26 Million represents 1% of operating cash flow (€160.69 Million). Read China Shineway Pharmaceutical Group Limi debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China Shineway Pharmaceutical Group Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for China Shineway Pharmaceutical Group Limited across 13 annual periods. Explore China Shineway Pharmaceutical Group Limi capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for China Shineway Pharmaceutical Group Limited. For the full company profile including market capitalisation, see China Shineway Pharmaceutical Group Limi (C1S) total market value.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | €974.13 Million | €1.17 Billion | €197.91 Million | ▼ -2.7% |
| 2024 | 0.85x | €823.02 Million | €963.13 Million | €140.11 Million | ▲ +1.1% |
| 2023 | 0.85x | €788.31 Million | €932.63 Million | €144.32 Million | ▼ -4.3% |
| 2022 | 0.88x | €980.21 Million | €1.11 Billion | €129.46 Million | ▲ +1.9% |
| 2021 | 0.87x | €609.52 Million | €703.15 Million | €93.63 Million | ▼ -3.3% |
| 2020 | 0.90x | €572.54 Million | €638.57 Million | €66.03 Million | ▲ +19.3% |
| 2019 | 0.75x | €276.59 Million | €368.00 Million | €88.40 Million | ▲ +1.9% |
| 2018 | 0.74x | €392.79 Million | €532.59 Million | €127.34 Million | ▼ -9.3% |
| 2017 | 0.81x | €398.82 Million | €490.65 Million | €91.83 Million | ▼ -29.0% |
| 2016 | 1.15x | €840.32 Million | €733.53 Million | €106.79 Million | ▲ +0.2% |
| 2015 | 1.14x | €851.26 Million | €744.71 Million | €106.56 Million | ▲ +0.7% |
| 2014 | 1.13x | €877.34 Million | €773.16 Million | €104.18 Million | ▼ -24.5% |
| 2013 | 1.50x | €781.77 Million | €519.89 Million | €261.89 Million | — |